{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:35Z","timestamp":1740107615210,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prognostic markers for meningioma recurrence are needed to guide patient management. Apart from rare hereditary syndromes, the impact of a previous unrelated tumor disease on meningioma recurrence has not been described before.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively searched our database for patients with meningioma WHO grade I and complete resection provided between 2002 and 2016. Demographical, clinical, pathological, and outcome data were recorded. The following covariates were included in the statistical model: age, sex, clinical history of unrelated tumor disease, and localization (skull base vs. convexity). Particular interest was paid to the patients\u2019 past medical history. The study endpoint was date of tumor recurrence on imaging. Prognostic factors were obtained from multivariate proportional hazards models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 976 meningioma patients diagnosed with a meningioma WHO grade I, 416 patients fulfilled our inclusion criteria. We encountered 305 women and 111 men with a median age of 57 years (range: 21\u201389 years). Forty-six patients suffered from a tumor other than meningioma, and no TERT mutation was detected in these patients. There were no differences between patients with and without a positive oncological history in terms of age, tumor localization, or mitotic cell count. Clinical history of prior tumors other than meningioma showed the strongest association with meningioma recurrence (<jats:italic>p<\/jats:italic> = 0.004, HR = 3.113, CI = 1.431\u20136.771) both on uni- and multivariate analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Past medical history of tumors other than meningioma might be associated with an increased risk of meningioma recurrence. A detailed pre-surgical history might help to identify patients at risk for early recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00701-021-04780-9","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T20:02:21Z","timestamp":1614974541000},"page":"2853-2859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I"],"prefix":"10.1007","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-5664","authenticated-orcid":false,"given":"Annamaria","family":"Biczok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Karschnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaela","family":"Vitalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Lenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Greve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Egensperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg-Christian","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schichor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"4780_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/annonc\/mdr398","volume":"23","author":"D Aune","year":"2012","unstructured":"Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ, Norat T (2012) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 23:843\u2013852. https:\/\/doi.org\/10.1093\/annonc\/mdr398","journal-title":"Ann Oncol"},{"key":"4780_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnci\/djn004","volume":"100","author":"L Bethke","year":"2008","unstructured":"Bethke L, Murray A, Webb E, Schoemaker M, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M et al (2008) Comprehensive analysis of DNA repair gene variants and risk of meningioma. JNCI: J Natl Cancer Instit 100:270\u2013276. https:\/\/doi.org\/10.1093\/jnci\/djn004","journal-title":"JNCI: J Natl Cancer Instit"},{"key":"4780_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","volume":"139","author":"A Biczok","year":"2018","unstructured":"Biczok A, Kraus T, Suchorska B, Terpolilli NA, Thorsteinsdottir J, Giese A, Tonn JC, Schichor C (2018) TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neuro-Oncol 139:671\u2013678. https:\/\/doi.org\/10.1007\/s11060-018-2912-7","journal-title":"J Neuro-Oncol"},{"key":"4780_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/neuonc\/nor130","volume":"13","author":"N Butowski","year":"2011","unstructured":"Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK et al (2011) Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro-Oncology 13:1331\u20131338. https:\/\/doi.org\/10.1093\/neuonc\/nor130","journal-title":"Neuro-Oncology"},{"key":"4780_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/aje\/kwj072","volume":"163","author":"AJ Canchola","year":"2006","unstructured":"Canchola AJ, Horn-Ross PL, Purdie DM (2006) Risk of second primary malignancies in women with papillary thyroid cancer. Am J Epidemiol 163:521\u2013527. https:\/\/doi.org\/10.1093\/aje\/kwj072","journal-title":"Am J Epidemiol"},{"key":"4780_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088\u20131095 discussion 1088-1095","journal-title":"Neurosurgery"},{"key":"4780_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3171\/2011.6.JNS11129","volume":"115","author":"EB Claus","year":"2011","unstructured":"Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M (2011) Family and personal medical history and risk of meningioma. J Neurosurg 115:1072\u20131077. https:\/\/doi.org\/10.3171\/2011.6.JNS11129","journal-title":"J Neurosurg"},{"key":"4780_CR8","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383\u2013e391. https:\/\/doi.org\/10.1016\/S1470-2045(16)30321-7","journal-title":"Lancet Oncol"},{"key":"4780_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3171\/2015.9.JNS15754","volume":"125","author":"K Gousias","year":"2016","unstructured":"Gousias K, Schramm J, Simon M (2016) The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg 125:551\u2013560. https:\/\/doi.org\/10.3171\/2015.9.JNS15754","journal-title":"J Neurosurg"},{"key":"4780_CR10","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3389\/fonc.2020.01522","volume":"10","author":"AF Haddad","year":"2020","unstructured":"Haddad AF, Young JS, Kanungo I, Sudhir S, Chen JS, Raleigh DR, Magill ST, McDermott MW, Aghi MK (2020) WHO Grade I meningioma recurrence: identifying high risk patients using histopathological features and the MIB-1 index. Front Oncol 10:1522. https:\/\/doi.org\/10.3389\/fonc.2020.01522","journal-title":"Front Oncol"},{"key":"4780_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2007-970554","volume":"17","author":"F Ildan","year":"2007","unstructured":"Ildan F, Erman T, Gocer AI, Tuna M, Bagdatoglu H, Cetinalp E, Burgut R (2007) Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base 17:157\u2013171. https:\/\/doi.org\/10.1055\/s-2007-970554","journal-title":"Skull Base"},{"key":"4780_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10552-014-0367-5","volume":"25","author":"A Kutsenko","year":"2014","unstructured":"Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P (2014) Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program. Cancer Causes Control 25:659\u2013668. https:\/\/doi.org\/10.1007\/s10552-014-0367-5","journal-title":"Cancer Causes Control"},{"key":"4780_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ijc.21950","volume":"119","author":"E Lee","year":"2006","unstructured":"Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F (2006) Association of meningioma with reproductive factors. Int J Cancer 119:1152\u20131157. https:\/\/doi.org\/10.1002\/ijc.21950","journal-title":"Int J Cancer"},{"key":"4780_CR14","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.21873\/anticanres.12526","volume":"38","author":"IAS Lombardi","year":"2018","unstructured":"Lombardi IAS, Faria MHG, Rabenhorst SHB, Zanini MA, Pardini MIDMC, RMT G, Ferrasi AC (2018) Hypermethylation of BRCA1 gene in meningioma in elderly males. Anticancer Res 38:2819\u20132822. https:\/\/doi.org\/10.21873\/anticanres.12526","journal-title":"Anticancer Res"},{"key":"4780_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"doi-asserted-by":"publisher","unstructured":"Materi J, Mampre D, Ehresman J, Rincon-Torroella J, Chaichana KL (2020) Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection. J Neurosurg 1\u20137. https:\/\/doi.org\/10.3171\/2019.10.JNS192466","key":"4780_CR16","DOI":"10.3171\/2019.10.JNS192466"},{"issue":"Suppl 4","key":"4780_CR17","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology 17(Suppl 4):iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro-Oncology"},{"key":"4780_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","volume":"117","author":"S Oya","year":"2012","unstructured":"Oya S, Kawai K, Nakatomi H, Saito N (2012) Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg 117:121\u2013128. https:\/\/doi.org\/10.3171\/2012.3.JNS111945","journal-title":"J Neurosurg"},{"key":"4780_CR19","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455\u20131465. https:\/\/doi.org\/10.1097\/00000478-199712000-00008","journal-title":"Am J Surg Pathol"},{"doi-asserted-by":"publisher","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T et al (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Instit 108. https:\/\/doi.org\/10.1093\/jnci\/djv377","key":"4780_CR20","DOI":"10.1093\/jnci\/djv377"},{"doi-asserted-by":"publisher","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","key":"4780_CR21","DOI":"10.1016\/S1470-2045(17)30155-9"},{"key":"4780_CR22","doi-asserted-by":"publisher","first-page":"e0181089","DOI":"10.1371\/journal.pone.0181089","volume":"12","author":"C Seliger","year":"2017","unstructured":"Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF (2017) Diabetes, use of metformin, and the risk of meningioma. PLoS One 12:e0181089. https:\/\/doi.org\/10.1371\/journal.pone.0181089","journal-title":"PLoS One"},{"key":"4780_CR23","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.18632\/oncotarget.13667","volume":"8","author":"C Seliger","year":"2017","unstructured":"Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF (2017) Metabolic syndrome in relation to risk of meningioma. Oncotarget 8:2284\u20132292. https:\/\/doi.org\/10.18632\/oncotarget.13667","journal-title":"Oncotarget"},{"key":"4780_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/2010.3.JNS091975","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue ME, Kane AJ, Shangari G, Parsa AT, Berger MS, McDermott MW (2010) Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg 113:1115\u20131121. https:\/\/doi.org\/10.3171\/2010.3.JNS091975","journal-title":"J Neurosurg"},{"key":"4780_CR25","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/00006123-199711000-00027","volume":"41","author":"JC Tonn","year":"1997","unstructured":"Tonn JC, Ott MM, Bouterfa H, Kerkau S, Kapp M, Muller-Hermelink HK, Roosen K (1997) Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas. Neurosurgery 41:1152\u20131159. https:\/\/doi.org\/10.1097\/00006123-199711000-00027","journal-title":"Neurosurgery"},{"doi-asserted-by":"publisher","unstructured":"Ueberschaer M, Vettermann FJ, Forbrig R, Unterrainer M, Siller S, Biczok AM, Thorsteinsdottir J, Cyran CC, Bartenstein P, Tonn JC et al (2020) Simpson grade revisited - intraoperative estimation of the extent of resection in meningiomas versus postoperative somatostatin receptor positron emission tomography\/computed tomography and magnetic resonance imaging. Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyaa333","key":"4780_CR26","DOI":"10.1093\/neuros\/nyaa333"},{"key":"4780_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/neuonc\/nos085","volume":"14","author":"B Wowra","year":"2012","unstructured":"Wowra B, Muacevic A, Furweger C, Schichor C, Tonn JC (2012) Therapeutic profile of single-fraction radiosurgery of vestibular schwannoma: unrelated malignancy predicts tumor control. Neuro-Oncology 14:902\u2013909. https:\/\/doi.org\/10.1093\/neuonc\/nos085","journal-title":"Neuro-Oncology"},{"key":"4780_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3171\/2013.10.JNS131357","volume":"120","author":"YS Yen","year":"2014","unstructured":"Yen YS, Sun LM, Lin CL, Chang SN, Sung FC, Kao CH (2014) Higher risk for meningioma in women with uterine myoma: a nationwide population-based retrospective cohort study. J Neurosurg 120:655\u2013661. https:\/\/doi.org\/10.3171\/2013.10.JNS131357","journal-title":"J Neurosurg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-021-04780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-021-04780-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-021-04780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T05:07:23Z","timestamp":1631509643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-021-04780-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4780"],"URL":"https:\/\/doi.org\/10.1007\/s00701-021-04780-9","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"type":"print","value":"0001-6268"},{"type":"electronic","value":"0942-0940"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"31 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Ludwig-Maximilians University (approval number: 18-837). Written informed consent was obtained before enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}